Rxsight
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $30,340 | $33,637 | $37,895 | $40,214 |
Gross Profit | 24,227 | 25,190 | 28,329 | 28,788 |
EBITDA | -8,948 | -10,964 | -7,381 | -5,398 |
EBIT | -9,802 | -11,749 | -8,166 | -5,921 |
Net Income | -9,816 | -11,786 | -8,190 | -5,938 |
Net Change In Cash | 30,340 | 33,637 | 37,895 | 40,214 |
Free Cash Flow | -1,768 | -5,913 | -9,407 | -5,107 |
Cash | 29,633 | 40,355 | 28,000 | 16,706 |
Basic Shares | 40,965 | 40,743 | 40,509 | 40,356 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $139,927 | $89,077 | $49,005 | $22,593 |
Gross Profit | 98,943 | 53,765 | 21,328 | 4,517 |
EBITDA | -23,760 | -41,037 | -57,779 | -41,010 |
EBIT | -27,384 | -45,280 | -61,801 | -44,998 |
Net Income | -27,455 | -48,608 | -66,756 | -48,688 |
Net Change In Cash | 139,927 | 89,077 | 49,005 | 22,593 |
Cost of Revenue | -12,568 | 10,727 | ||
Free Cash Flow | -22,386 | -46,407 | -61,243 | -46,648 |
Cash | 16,706 | 9,692 | 11,834 | 24,361 |
Basic Shares | 38,867 | 34,455 | 27,661 | 27,366 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.04 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.03 |
